|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Institute of Cardiovascular Sciences and Department of Physiology, Faculty of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada
* To whom correspondence should be addressed. E-mail: nsdhalla{at}sbrc.ca.
Unlike most of other experimental models of congestive heart failure, the volume overload induced by aortocaval shunt (AVS) in rats was found to exhibit enhanced
-
adrenoceptor (
-AR) signaling. To study whether the adenylyl cyclase (AC)-G-protein system is involved in such a change, we examined cardiac AC activity and protein
content as well as Gs
- and Gi
-activities, protein contents and mRNA levels in both left and right ventricles (LV and RV) at the failing stage (16 weeks post-surgery). The basal and forskolin stimulated AC activities were significantly increased in both LV and RV from the failing hearts; this change was associated with an upregulation of type V/VI AC protein. In contrast to Gpp(NH)p and NaF, the stimulatory effect of isoproterenol on AC
was increased in the failing heart. Although Gs
- and Gi
-protein contents in the failing hearts were not altered, mRNA level for Gs
was decreased by 20% and that for Gi
was increased by 20%. In addition, the activity of Gs
, but not Gi
, as assessed by toxin catalyzed ADP-ribosylation, was significantly decreased in the failing heart. Losartan
and imidapril treatments improved cardiac function and attenuated alterations in mRNA levels for Gs
- and Gi
-proteins, as well as Gs
activity without affecting changes in AC protein content or activities in heart failure due to volume overload. These data suggest that increased AC activity may contribute to the enhanced
-AR signaling in the AVS model of heart failure whereas alterations in gene expression for G-proteins may be of adaptive nature at this stage of heart failure.
This article has been cited by other articles:
![]() |
N. S. Dhalla, H. K. Saini-Chohan, D. Rodriguez-Leyva, V. Elimban, M. R. Dent, and P. S. Tappia Subcellular remodelling may induce cardiac dysfunction in congestive heart failure Cardiovasc Res, October 30, 2008; (2008) cvn281v2. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Sethi, H. K. Saini, X. Guo, X. Wang, V. Elimban, and N. S. Dhalla Dependence of changes in beta-adrenoceptor signal transduction on type and stage of cardiac hypertrophy J Appl Physiol, March 1, 2007; 102(3): 978 - 984. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. S. Dhalla, M. R. Dent, P. S. Tappia, R. Sethi, J. Barta, and R. K. Goyal Subcellular Remodeling as a Viable Target for the Treatment of Congestive Heart Failure Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2006; 11(1): 31 - 45. [Abstract] [PDF] |
||||
![]() |
X. Wang, E. Sentex, H. K. Saini, D. Chapman, and N. S. Dhalla Upregulation of {beta}-adrenergic receptors in heart failure due to volume overload Am J Physiol Heart Circ Physiol, July 1, 2005; 289(1): H151 - H159. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |